Higher blood fats more harmful than first thought 

University of Leeds news 

Embargo: Friday 1 April, 10am London time 

Increased levels of blood fats in people with type 2 diabetes and obesity are more harmful than previously thought, a new study has found. 

In patients with metabolic diseases, elevated fat levels in the blood create stress in muscle cells – a reaction to changes outside the cell which damage their structure and function.  

University of Leeds researchers have discovered that these stressed-out cells give off a signal which can be passed on to other cells. 

The signals, known as ceramides, may have a protective benefit in the short-term, because they are part of a mechanism designed to reduce stress in the cell. But in metabolic diseases, which are long term conditions, the signals can kill the cells, make symptoms more severe, and worsen the illness. 

Increased fat in the blood has long been known to damage tissues and organs, contributing to the development of cardiovascular and metabolic diseases including type 2 diabetes. The condition can be caused by obesity, rates of which have nearly tripled worldwide since 1975. In 2016, there were more than 650 million adults aged 18 and above with obesity. 

Research supervisor Lee Roberts, Professor of Molecular Physiology and Metabolism in the University of Leeds’s School of Medicine, said: “Although this research is at an early stage, our discovery may form the basis of new therapies or therapeutic approaches to prevent the development of cardiovascular and metabolic diseases such as diabetes in people with elevated blood fats in obesity.” 

In the lab, the team replicated the blood fat levels observed in humans with metabolic disease by exposing skeletal muscle cells to a fatty acid called palmitate. The cells began to transmit the ceramide signal.  

When these cells were mixed with others which had not been previously exposed to fats, the researchers found that they communicated with each other, transporting the signal in packages called extracellular vesicles.  

The experiment was reproduced in human volunteers with metabolic diseases and gave comparable results. The findings provide a completely new angle on how cells respond to stress, with important consequences for our understanding of certain metabolic diseases including obesity. 

Professor Roberts said: “This research gives us a novel perspective on how stress develops in the cells of individuals with obesity, and provides new pathways to consider when looking to develop new treatments for metabolic diseases.  

“With obesity an ever-increasing epidemic, the burden of associated chronic disease such as type 2 diabetes necessitates new treatments. We hope the results of our research here open a new avenue for research to help address this growing concern.” 

The paper, titled ‘Long-chain ceramides are cell non-autonomous signals linking lipotoxicity to endoplasmic reticulum stress in skeletal muscle’, is published today in ‘Nature Communications’. 

The international research team included colleagues from the University of Cambridge, the University of Bonn, University of Bari, Imperial College and AstraZeneca. 

Further information 

Contact University of Leeds press officer Lauren Ballinger via [email protected] with media enquiries. 

DOI: 10.1038/s41467-022-29363-9.

University of Leeds  

The University of Leeds is one of the largest higher education institutions in the UK, with more than 38,000 students from more than 150 different countries. We are renowned globally for the quality of our teaching and research.  

We are a values-driven university, and we harness our expertise in research and education to help shape a better future for humanity, working through collaboration to tackle inequalities, achieve societal impact and drive change.   

The University is a member of the Russell Group of research-intensive universities, and plays a significant role in the Turing, Rosalind Franklin and Royce Institutes. www.leeds.ac.uk   

Follow University of Leeds or tag us in to coverage: Twitter | Facebook | LinkedIn | Instagram